Jun 04, 2017 7:00am EDT Pieris Pharmaceuticals Announces Presentation of Clinical Data for Anemia Drug Candidate, PRS-080, at the 54th ERA-EDTA Congress
Jun 01, 2017 6:19pm EDT Pieris Pharmaceuticals to Present at The Jefferies 2017 Global Healthcare Conference on Friday, June 9th at 9:00 am EDT
May 10, 2017 5:36pm EDT Pieris Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2017 and Provides Corporate Update
May 03, 2017 7:30am EDT Pieris Pharmaceuticals to Host Conference Call on Strategic Alliance With AstraZeneca
May 03, 2017 2:00am EDT Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
May 01, 2017 7:30am EDT Pieris Pharmaceuticals to Host First Quarter 2017 Investor Call and Corporate Update on May 11, 2017
Apr 04, 2017 7:30am EDT Pieris Pharmaceuticals Presents IND-enabling Data for Bispecific Immuno-Oncology Drug Candidate, PRS-343, in Poster Session at the 2017 Meeting of the American Association for Cancer Research (AACR)
Mar 22, 2017 8:18pm EDT Pieris Pharmaceuticals Reports Full-Year 2016 Financial Results and Corporate Update
Mar 15, 2017 7:30am EDT Pieris Pharmaceuticals to Host Full-Year 2016 Investor Call And Corporate Update on March 23, 2017
